These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16006125)

  • 21. 15-Deoxy-Δ
    Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
    Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ as an electrophilic mediator.
    Shibata T
    Biosci Biotechnol Biochem; 2015; 79(7):1044-9. PubMed ID: 26011133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
    Lee DR; Kwon CH; Park JY; Kim YK; Woo JS
    Toxicology; 2009 Apr; 258(1):17-24. PubMed ID: 19167456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses.
    Uchida K; Shibata T
    Chem Res Toxicol; 2008 Jan; 21(1):138-44. PubMed ID: 18052108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?
    Powell WS
    J Clin Invest; 2003 Sep; 112(6):828-30. PubMed ID: 12975467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-Deoxy-Delta(12,14)-prostaglandin J(2) impairs the functions of histone acetyltransferases through their insolubilization in cells.
    Hironaka A; Morisugi T; Kawakami T; Miyagi I; Tanaka Y
    Biochem Biophys Res Commun; 2009 Dec; 390(2):290-4. PubMed ID: 19799872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 15-Deoxy-Δ
    Nilsson L; Palm F; Nørregaard R
    Mediators Inflamm; 2017; 2017():3924912. PubMed ID: 28503033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2.
    Pérez-Sala D; Cernuda-Morollón E; Cañada FJ
    J Biol Chem; 2003 Dec; 278(51):51251-60. PubMed ID: 14532268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
    Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
    Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective.
    Renedo M; Gayarre J; García-Domínguez CA; Pérez-Rodríguez A; Prieto A; Cañada FJ; Rojas JM; Pérez-Sala D
    Biochemistry; 2007 Jun; 46(22):6607-16. PubMed ID: 17489560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
    Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
    Kim HY; Kim JR; Kim HS
    J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin as a molecular target of cyclopentenone prostaglandins.
    Shibata T; Yamada T; Ishii T; Kumazawa S; Nakamura H; Masutani H; Yodoi J; Uchida K
    J Biol Chem; 2003 Jul; 278(28):26046-54. PubMed ID: 12709421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S; Kato H; Kobayashi Y; Ito W; Adachi T; Nagase H; Ohta K; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():15-22. PubMed ID: 17541271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
    Sánchez-Gómez FJ; Gayarre J; Avellano MI; Pérez-Sala D
    Arch Biochem Biophys; 2007 Jan; 457(2):150-9. PubMed ID: 17169324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation.
    Han H; Shin SW; Seo CY; Kwon HC; Han JY; Kim IH; Kwak JY; Park JI
    Apoptosis; 2007 Nov; 12(11):2101-14. PubMed ID: 17786557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAP kinase phosphatase-1 expression is regulated by 15-deoxy-Δ12,14-prostaglandin J2 via a HuR-dependent post-transcriptional mechanism.
    Woo JH; Lee JH; Kim H; Choi Y; Park SM; Joe EH; Jou I
    Biochim Biophys Acta; 2015 Jun; 1849(6):612-25. PubMed ID: 25805336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
    Coyle AT; O'Keeffe MB; Kinsella BT
    FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.